Literature DB >> 8945611

Familial aggregation of colorectal cancer in the general population.

B Carstensen1, H Soll-Johanning, E Villadsen, J O Søndergaard, E Lynge.   

Abstract

To investigate the familial aggregation of colorectal cancer in Denmark, parents and siblings of colorectal cancer patients diagnosed below age 60 years in the years 1982-1984 were identified through population registries. For 1,470 probands with families eligible for tracing, 1,376 mothers, 1,303 fathers and 3,259 siblings were identified. They contributed 222,634 person-years, and 325 cases of colorectal cancer were observed during the follow-up period 1943-1992. All data were retrieved from population registries and consequently were free from any reporting bias. The overall standardized morbidity ratio (SMR) compared with the Danish population was 2.02 (95% confidence interval [CI] 1.81-2.25), significantly different between the parents (1.78, 95% CI 1.55-2.04) and the siblings (2.65, 95% CI 2.21-3.17). A strong dependence on the proband's age at diagnosis was seen for the sibling risk; siblings of probands less than 50 years old at diagnosis had a 5-fold risk compared with the general population. This dependence was not seen for parents, but the risk tended to be higher for parents of younger ages. No other factor was seen to influence the relative risk. The observation of an 80% increased risk among the parents and a 170% increased risk among the siblings indicates that the genetic component is one source, but probably not the only one, of familial aggregation of colorectal cancer. The cost benefit of screening siblings of colorectal cancer patients is substantially higher than that for the total population.

Entities:  

Mesh:

Year:  1996        PMID: 8945611     DOI: 10.1002/(SICI)1097-0215(19961115)68:4<428::AID-IJC5>3.0.CO;2-2

Source DB:  PubMed          Journal:  Int J Cancer        ISSN: 0020-7136            Impact factor:   7.396


  17 in total

1.  Dietary phytoestrogen intake is associated with reduced colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan Okey; Patricia Harper
Journal:  J Nutr       Date:  2006-12       Impact factor: 4.798

Review 2.  Screening participation for people at increased risk of colorectal cancer due to family history: a systematic review and meta-analysis.

Authors:  Driss Ait Ouakrim; Trevor Lockett; Alex Boussioutas; John L Hopper; Mark A Jenkins
Journal:  Fam Cancer       Date:  2013-09       Impact factor: 2.375

Review 3.  Serrated pathway colorectal cancer in the population: genetic consideration.

Authors:  Joanne Young; Mark Jenkins; Susan Parry; Bruce Young; Derek Nancarrow; Dallas English; Graham Giles; Jeremy Jass
Journal:  Gut       Date:  2007-06-12       Impact factor: 23.059

4.  Colorectal cancer screening in patients at moderately increased risk due to family history.

Authors:  Otto S Lin
Journal:  World J Gastrointest Oncol       Date:  2012-06-15

5.  Screening practices of unaffected people at familial risk of colorectal cancer.

Authors:  Driss Ait Ouakrim; Alex Boussioutas; Trevor Lockett; Ingrid Winship; Graham G Giles; Louisa B Flander; Louise Keogh; John L Hopper; Mark A Jenkins
Journal:  Cancer Prev Res (Phila)       Date:  2011-10-26

Review 6.  Evidenced-Based Screening Strategies for a Positive Family History.

Authors:  Jennifer M Kolb; Dennis J Ahnen; N Jewel Samadder
Journal:  Gastrointest Endosc Clin N Am       Date:  2020-04-14

7.  Preoperative evaluation and oncologic principles of colon cancer surgery.

Authors:  Matthew L Lynch; Marc I Brand
Journal:  Clin Colon Rectal Surg       Date:  2005-08

8.  Red meat intake, doneness, polymorphisms in genes that encode carcinogen-metabolizing enzymes, and colorectal cancer risk.

Authors:  Michelle Cotterchio; Beatrice A Boucher; Michael Manno; Steven Gallinger; Allan B Okey; Patricia A Harper
Journal:  Cancer Epidemiol Biomarkers Prev       Date:  2008-11       Impact factor: 4.254

9.  The Swedish family-cancer database: update, application to colorectal cancer and clinical relevance.

Authors:  Kari Hemminki; Charlotta Granström; Bowang Chen
Journal:  Hered Cancer Clin Pract       Date:  2005-01-15       Impact factor: 2.857

10.  Meta-analyses of colorectal cancer risk factors.

Authors:  Constance M Johnson; Caimiao Wei; Joe E Ensor; Derek J Smolenski; Christopher I Amos; Bernard Levin; Donald A Berry
Journal:  Cancer Causes Control       Date:  2013-04-06       Impact factor: 2.506

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.